Home/Teclison/Kuenhi Tsai, PhD
KT

Kuenhi Tsai, PhD

SVP of Clinical Research

Teclison

Therapeutic Areas

Teclison Pipeline

DrugIndicationPhase
TEC-001 (with TATE)Colorectal CancerPhase 2
TEC-001 + OpdivoLiver Cancer (Advanced stage)Phase 2
TEC-001 + KeytrudaLung CancerPhase 2
TEC-002Solid TumorsPreclinical
TEC-003Solid TumorsPreclinical